Paradigm shift from diagnosing patients based on common symptoms to categorizing patients into subtypes with different pathogenic mechanisms to guide treatment for Alzheimer’s disease
Keiro Shirotani; Masashi Asai; Nobuhisa Iwata
Author Information: Department of Genome-based Drug Discovery, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki 852-8521, Japan
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.